The Effects of Prostaglandin E1 on Megakaryocyte Proliferation In Vitro

  • George W. Cooper
  • Xiao Ping Hou
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 34)


A concentration of 560 nM Prostaglandin E1 (PGE1), in a medium containing either 10% serum and 10% plasma, or 20% plasma and a platelet extract prepared from 24 × 106 platelets/ml, caused after four days of incubation in a plasma clot culture system, highly significant increases over the controls in both the number of megakaryocyte colonies/clot and megakaryocytes/clot. A linear dose-response relationship over the entire 14–560 nM range was also demonstrated in cultures containing serum, between the concentration of PGE1 in each culture, and the number of megakaryocyte colonies/clot and megakaryocytes/clot. However, PGE1 did not appear to stimulate megakaryocytes in cultures containing only 20% rat plasma.


Isotonic Saline Saline Control Plasma Clot Pokeweed Mitogen Platelet Extract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Williams, N. 1979. Preferential inhibition of murine macrophage colony formation by prostaglandin E. Blood 53: 1089–1094.Google Scholar
  2. 2.
    Antoniades, H.N. 1981. Human platelet-derived growth factor (PDGF). Purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc. Natl. Acad. Sci. USA 78: 7314–7317.PubMedCrossRefGoogle Scholar
  3. 3.
    Karnovsky, M.J., and L. Roots. 1964. A “direct-coloring” thiocholine method for cholinesterase. J. Histochem. Cytochem. 12: 219–221.PubMedCrossRefGoogle Scholar
  4. 4.
    Cooper, G.W., H. Dinowitz, and B. Cooper. 1984. The effects of administration of ethyl alcohol to mice on megakaryocyte and platelet development. Throm. Haemostas. 52: 11–14.Google Scholar
  5. 5.
    Stiles, C.D. 1983. The molecular biology of platelet-derived growth factor. Cell 33: 653–655.PubMedCrossRefGoogle Scholar
  6. 6.
    Sporn, M.B., and A.B. Roberts. 1986. Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest. 78: 329–332.PubMedCrossRefGoogle Scholar
  7. 7.
    Sporn, M.B., A.B. Roberts, L.M. Wakefield, and R.K. Assoian. 1986. Transforming growth factor-3. Biological function and chemical structure. Science 233: 532–534.PubMedCrossRefGoogle Scholar
  8. 8.
    Shier, W.T. 1980. Serum stimulation of phospholipase A and prostaglandin release in 3T3 cells associated with platelet-derived growth-promoting activity. Proc. Natl. Acad. Sci. USA. 77: 137–141.PubMedCrossRefGoogle Scholar
  9. 9.
    Coughlin, S.R., M.A. Moskowitz, B.R. Zetter, H.N. Antoniades, and L. Levine. 1980. Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature (London). 288: 600–602.CrossRefGoogle Scholar
  10. 10.
    Coughlin, S.R., M.A. Moskowitz, H.N. Antoniades, and L. Levine. Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet- derived growth factor. Proc. Natl. Acad. Sci. USA. 78: 7134–7138.Google Scholar
  11. 11.
    Tasjian, A., Jr., E.L. Hohmann, H.N. Antoniades, and L. Levine. 1982. Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. Endocrinol. III: 118–124.CrossRefGoogle Scholar
  12. 12.
    Dukes, P.P. 1972. Modulating effects of erythropoietin, prostaglandins and cyclic 3’5’ nuclotides on erythroid differentiation in marrow cell culture. Fed. Proc. 31: 487. (abstr.).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • George W. Cooper
    • 1
  • Xiao Ping Hou
    • 1
  1. 1.Department of BiologyThe City College of the City University of New YorkNew YorkUSA

Personalised recommendations